BRBR BellRing Brands, Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
17:19
Aug 25
Aug 25
BellRing pure-play, wait for entry.
Watch BellRing as a protein shake pure play. The author acknowledges margin pressure but frames this as a category beneficiary, not a personal pick. A wait-and-see approach is warranted.
MED
01:22
Jun 06
Jun 06
Index rebalancing forced Campbell's, Bellring Brands, and Coty into lower market-cap tiers.
Index rebalancing forced Campbell's, Bellring Brands, and Coty into lower market-cap tiers, a structural shift with no author position.
15:17
Jun 01
Jun 01
50 million US adults now use GLP‑1 drugs, increasing protein intake ~65%. Whey prices are up 50%+ YTD, and some protein manufacturers have sold out for the year. BRBR’s Premier Protein is one of the few brands that passed heavy‑metal tests, giving it a quality moat that can capture the GLP‑1‑driven demand surge. As a publicly traded pure‑play protein powder company with strong brand recognition, BRBR is poised to benefit from a structural demand shift that the market has not fully priced in. Rising whey input costs could compress margins; increased competition from cheaper alternatives (cottage cheese, plant‑based), and the GLP‑1 trend may slow or face regulatory headwinds.
HIGH
17:44
May 29
May 29
Stock fell 89% from $78 to $8.44; company guided 0-2% growth vs prior 5%, EBITDA down to $320M from $450M, gross margins compressed from 35% to 22% due to Costco price pressure. Author believes the market overreacted; with market cap ~$1B and $500M remaining buyback authorization, the company could retire half the float, supporting a recovery to $25 (3x current price). Contrarian long on a fallen angel with massive buyback tailwind; bet on margin stabilization and mean reversion once price war subsides. Continued margin compression from Costco/pricing competition, further demand weakness, execution risk on buyback (if debt/cash flow issues arise).
HIGH
16:49
May 10
May 10
Barbarian Capital highlights a rough earnings season for former growth darlings in staples.
Barbarian Capital highlights a rough earnings season for former growth darlings in staples and discretionary sectors, with PAA Research explicitly calling $BRBR a poster child for shareholder value destruction via buybacks.
HIGH
16:00
May 07
May 07
The tweet reports a day of significant double-digit declines in consumer staples.
The tweet reports a day of significant double-digit declines in consumer staples and discretionary stocks, including PLNT, SHAK, VITL, TPR, WHR, COKE, and BRBR, but provides no forward-looking opinion or trade thesis.
HIGH
14:13
May 06
May 06
BRBR named as a short candidate in Hedgeye's Signal Strength stock basket.
BRBR named as a short candidate in Hedgeye's Signal Strength stock basket; no personal position or catalyst disclosed by speaker.
LOW
21:14
May 05
May 05
Short BRBR as a "Core Short" in Hedgeye's process.
Short BRBR as a "Core Short" in Hedgeye's process — the stock is declining idiosyncratically even as SPY prints all-time highs, demonstrating strong bearish momentum independent of the broader market tape.
MED
15:21
May 05
May 05
Hedgeye Staples analyst Biolsi issues a SELL call on BRBR.
Hedgeye Staples analyst Biolsi issues a SELL call on BRBR; short on the back of a fresh institutional sell-side conviction call from a named sector analyst.
MED
00:18
Apr 24
Apr 24
Stock down ~80% while revenue remains ~$2.3B; valuation at 8x NTM EBITDA and 1.3x NTM revenue suggests deep pessimism. If the business is not structurally broken and cyclical headwinds (whey, tariffs, competition) ease, the multiple could re-rate higher, providing upside. A contrarian value play on a de-rated staple brand with resilient distribution and revenue. Sustained whey inflation, tariff escalation, or loss of club channel shelf space could undermine the thesis.
MED
23:45
Feb 28
Feb 28
The stock has drawn down significantly (cited as falling from ~$80 to ~$17), trading at ~9x EV/EBITDA and an 11% Free Cash Flow yield, with an 80% ROIC due to its asset-light, outsourced manufacturing model. The market has likely over-penalized the stock due to GLP-1 weight-loss drug fears or momentum selling. However, the "Premier Protein" brand has strong distribution and sticky demand (protein is essential regardless of weight loss methods), creating a dislocation between price and business quality. LONG (Deep Value). Competition from private labels (e.g., Costco/Kirkland); single-category reliance; potential impact of GLP-1s on consumption habits.
10:12
Jan 15
Jan 15
Oversold protein stock, margin recovery upside
The author argues BellRing Brands, owner of Premier Protein and Dymatize, is down almost 70% over the past year because margins fell and costs rose, but the market now assumes margins stay permanently depressed and growth slows a lot. If margins recover even part of the way over the next couple of years and growth stays decent, the upside could be meaningful, while downside from here seems more limited than a year ago. The author cites real challenges including competition, higher protein costs, advertising spend, and heavy exposure to the club channel. The catalyst is a partial margin recovery over the next couple of years, tied to the protein/convenience nutrition trend.
HIGH
19:38
Jan 08
Jan 08
Hated protein maker with cheap multiple and solid growth
The author argues BRBR is a hated stock trading 66% below its 52-week high and hitting new lows despite a cheap multiple and solid growth. The catalyst cited is a new 'eat more protein' recommendation that drove an 8% gain on the day. The author views it as worth tracking, though no specific risk is mentioned.
HIGH
About BRBR Investor Commentary
Across the available history and selected sources, Buzzberg tracks BRBR (BellRing Brands, Inc.) across 6 sources: 5 bullish vs 2 bearish calls from 7 authors. Historical directional balance: 23% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 13 total trade ideas tracked. Latest voices: TheValueist, BarbarianCap, u/christophbeatty.